PP_1170x120_10-25-21

American Regent

American Regent introduces estradiol valerate injection

American Regent introduces estradiol valerate injection

SHIRLEY, N.Y. — American Regent announces the introduction and availability of estradiol valerate injection, USP – AO Rated and therapeutically equivalent to Delestrogen. Estradiol valerate injection is indicated in the: Treatment of moderate to severe vasomotor symptoms associated with the menopause. Treatment of moderate to severe symptoms of vulvar and vaginal atrophy associated with the

American Regent introduces Nicardipine Hydrochloride Injection

American Regent introduces Nicardipine Hydrochloride Injection

SHIRLEY, N.Y. — American Regent announced the introduction of the only FDA approved USP standard Nicardipine Hydrochloride Injection. Nicardipine Hydrochloride is a calcium channel blocker indicated for the short-term treatment of hypertension when oral therapy is not feasible. “American Regent is pleased to be bringing back this shortage-prone product in a USP formulation, and to